Skip to main content
AMN
NYSE Trade & Services

AMN Healthcare Exceeds Q4 Expectations, Projects Strong Q1 Revenue Boosted by Labor Disruption Events

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$16.6
Mkt Cap
$663.79M
52W Low
$14.865
52W High
$30.49
Market data snapshot near publication time

summarizeSummary

AMN Healthcare reported Q4 2025 results that exceeded expectations and provided strong Q1 2026 revenue guidance, significantly boosted by temporary labor disruption events, alongside substantial debt reduction.


check_boxKey Events

  • Q4 2025 Results Exceed Expectations

    The company reported Q4 2025 revenue of $748.2 million and adjusted diluted EPS of $0.22, exceeding its own expectations due to strong performance in nurse and allied staffing, including revenue from a large labor disruption event.

  • Strong Q1 2026 Revenue Guidance

    AMN Healthcare projects Q1 2026 consolidated revenue between $1.225 billion and $1.240 billion, representing a significant 78-80% increase year-over-year. This guidance includes approximately $600 million in revenue from labor disruption events.

  • Significant Debt Reduction in 2025

    The company reduced its total debt by $285 million during 2025, ending the year with $775 million in total debt outstanding, improving its financial leverage.

  • Year-over-Year Profitability Declines

    Despite exceeding Q4 expectations, adjusted diluted EPS for Q4 2025 decreased by 70% year-over-year to $0.22, and full-year adjusted diluted EPS declined by 59% to $1.36, reflecting broader market shifts.


auto_awesomeAnalysis

AMN Healthcare Services reported fourth quarter 2025 financial results that surpassed its own expectations, driven by better performance in nurse and allied staffing, including revenue from a significant labor disruption event. While the company experienced year-over-year declines in adjusted diluted EPS and Adjusted EBITDA for both Q4 and the full year 2025, the immediate outlook is strong. The company provided robust Q1 2026 revenue guidance, projecting a substantial increase of 78-80% year-over-year, largely due to an anticipated $600 million from ongoing labor disruption events. Additionally, AMN Healthcare demonstrated financial discipline by reducing its total debt by $285 million in 2025, ending the year with $775 million outstanding. Investors will likely focus on the strong near-term revenue growth and debt reduction, while also considering the temporary nature of the labor disruption revenue.

At the time of this filing, AMN was trading at $16.60 on NYSE in the Trade & Services sector, with a market capitalization of approximately $663.8M. The 52-week trading range was $14.87 to $30.49. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed AMN - Latest Insights

AMN
Mar 18, 2026, 8:00 AM EDT
Filing Type: DEF 14A
Importance Score:
8
AMN
Feb 19, 2026, 6:15 PM EST
Filing Type: 10-K
Importance Score:
8
AMN
Feb 19, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
AMN
Jan 14, 2026, 9:01 AM EST
Filing Type: 8-K
Importance Score:
7